Yuehua Decoction Impact on MDR-TB Quality of Life and Safety: A 71-Patient Cohort Study

A supplementary document from a prospective cohort study on 71 patients with multidrug-resistant tuberculosis. The study, authored by Qingfeng Sun, evaluates the impact of adjunctive Yuehua Decoction on health-related quality of life and safety outcomes, with data last updated in April 2026. The file contains the study's background, methods, results, and conclusions.

Use Cases

• Analyzing the association between traditional Chinese medicine and patient-reported outcomes based on St. George's Respiratory Questionnaire scores.
• Comparing adverse event rates between treatment groups based on reported incidences of skin reactions.
• Reviewing clinical study methodology for non-randomized cohort designs in tuberculosis research.

Strengths

• Study results include specific statistical measures, such as an adjusted β coefficient of -3.00 for SGRQ improvement.
• The document provides a detailed breakdown of patient group sizes (Yuehua group n=32, control group n=39).
• It reports on multiple clinical outcomes, including sputum culture conversion and adverse events.

Limitations

• The dataset is a 13.3 KB DOCX file, indicating a very limited scope and likely containing only textual study results, not raw patient data.
• Column-level documentation is absent; field semantics must be inferred after download.
• Row count is unknown, which may limit suitability assessment for quantitative analysis.

Provenance

Source

figshare, author Qingfeng Sun

Collection Method

Data likely originates from a prospective, non-randomized clinical cohort study.

Time Range

The study period is not specified, but the document was updated in 2026.

Freshness

Last updated 2026-04-16 04:19:23

Geography

The geographic coverage of the patient cohort is not specified.